{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,5,14]],"date-time":"2023-05-14T05:11:04Z","timestamp":1684041064106},"reference-count":30,"publisher":"Elsevier BV","issue":"43","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1016\/j.vaccine.2007.08.049","type":"journal-article","created":{"date-parts":[[2007,9,17]],"date-time":"2007-09-17T12:21:33Z","timestamp":1190031693000},"page":"7481-7490","source":"Crossref","is-referenced-by-count":2,"title":["Semliki Forest virus vectors expressing the H and HN genes of measles and mumps viruses reduce immunity induced by the envelope protein genes of rubella virus"],"prefix":"10.1016","volume":"25","author":[{"given":"Sara J.","family":"Callagy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara J.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina N.","family":"Fleeton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian J.","family":"Sheahan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sareen E.","family":"Galbraith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory J.","family":"Atkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.vaccine.2007.08.049_bib1","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1615\/CritRevImmunol.v23.i4.40","article-title":"Is an improved measles\u2013mumps\u2013rubella vaccine necessary or feasible?","volume":"23","author":"Atkins","year":"2003","journal-title":"Crit Rev Immunol"},{"issue":"15\u201316","key":"10.1016\/j.vaccine.2007.08.049_bib2","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1016\/S0264-410X(98)00371-5","article-title":"Development of a rubella virus DNA vaccine","volume":"17","author":"Pougatcheva","year":"1999","journal-title":"Vaccine"},{"issue":"25\u201326","key":"10.1016\/j.vaccine.2007.08.049_bib3","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1016\/S0264-410X(03)00271-8","article-title":"Unintended events following immunization with MMR: a systematic review","volume":"21","author":"Jefferson","year":"2003","journal-title":"Vaccine"},{"issue":"5","key":"10.1016\/j.vaccine.2007.08.049_bib4","doi-asserted-by":"crossref","first-page":"3252","DOI":"10.4049\/jimmunol.175.5.3252","article-title":"Wild-type measles virus infection in human CD46\/CD150-transgenic mice: CD11c-positive dendritic cells establish systemic viral infection","volume":"175","author":"Shingai","year":"2005","journal-title":"J Immunol"},{"issue":"8","key":"10.1016\/j.vaccine.2007.08.049_bib5","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1016\/j.biocel.2004.01.019","article-title":"Measles: immune suppression and immune responses","volume":"36","author":"Moss","year":"2004","journal-title":"Int J Biochem Cell Biol"},{"issue":"1","key":"10.1016\/j.vaccine.2007.08.049_bib6_1","first-page":"28","article-title":"Alphavirus-based vaccines","volume":"4","author":"Lundstrom","year":"2002","journal-title":"Curr Opin Mol Ther"},{"issue":"7","key":"10.1016\/j.vaccine.2007.08.049_bib6_2","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1099\/0022-1317-78-7-1559","article-title":"Death mechanisms in cultured cells infected by Semliki Forest virus","volume":"78","author":"Glasgow","year":"1997","journal-title":"J Gen Virol"},{"issue":"10","key":"10.1016\/j.vaccine.2007.08.049_bib7","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1099\/0022-1317-79-10-2405","article-title":"The Semliki Forest virus vector induces p53-independent apoptosis","volume":"79","author":"Glasgow","year":"1998","journal-title":"J Gen Virol"},{"issue":"28\u201329","key":"10.1016\/j.vaccine.2007.08.049_bib8","doi-asserted-by":"crossref","first-page":"3877","DOI":"10.1016\/S0264-410X(01)00126-8","article-title":"Recombinant Semliki Forest virus particles encoding the prME or NS1 proteins of louping ill virus protect mice from lethal challenge","volume":"19","author":"Morris-Downes","year":"2001","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2007.08.049_bib9","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1099\/0022-1317-81-3-749","article-title":"Recombinant Semliki Forest virus particles expressing louping ill virus antigens induce a better protective response than plasmid-based DNA vaccines or an inactivated whole particle vaccine","volume":"81","author":"Fleeton","year":"2000","journal-title":"J Gen Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2007.08.049_bib10","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1099\/vir.0.18738-0","article-title":"Construction and immunogenicity in a prime-boost regimen of a Semliki Forest virus-vectored experimental HIV clade A vaccine","volume":"84","author":"Hanke","year":"2003","journal-title":"J Gen Virol"},{"issue":"5","key":"10.1016\/j.vaccine.2007.08.049_bib11","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0264-410X(98)00224-2","article-title":"Immunization with recombinant Semliki Forest virus induces protection against influenza challenge in mice","volume":"17","author":"Berglund","year":"1999","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2007.08.049_bib12","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1007\/s007050050150","article-title":"Genomic sequence of the RA27\/3 vaccine strain of rubella virus","volume":"142","author":"Pugachev","year":"1997","journal-title":"Arch Virol"},{"issue":"4","key":"10.1016\/j.vaccine.2007.08.049_bib13","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.vaccine.2004.06.030","article-title":"A recombinant rubella virus E1 glycoprotein as a rubella vaccine candidate","volume":"23","author":"Perrenoud","year":"2004","journal-title":"Vaccine"},{"issue":"1\u20132","key":"10.1016\/j.vaccine.2007.08.049_bib14","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0168-1702(00)00254-9","article-title":"Localization of a new neutralizing epitope on the mumps virus hemagglutinin\u2013neuraminidase protein","volume":"74","author":"Cusi","year":"2001","journal-title":"Virus Res"},{"issue":"33","key":"10.1016\/j.vaccine.2007.08.049_bib15","doi-asserted-by":"crossref","first-page":"11581","DOI":"10.1073\/pnas.0504592102","article-title":"Modulation of disease, T cell responses, and measles virus clearance in monkeys vaccinated with H-encoding alphavirus replicon particles","volume":"102","author":"Pan","year":"2005","journal-title":"PNAS"},{"issue":"9","key":"10.1016\/j.vaccine.2007.08.049_bib16","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1128\/JCM.30.9.2323-2329.1992","article-title":"Cellular and humoral immune responses to rubella virus structural proteins E1, E2, and C","volume":"30","author":"Chaye","year":"1992","journal-title":"J Clin Microbiol"},{"issue":"11","key":"10.1016\/j.vaccine.2007.08.049_bib17","doi-asserted-by":"crossref","first-page":"5500","DOI":"10.1128\/JVI.64.11.5500-5509.1990","article-title":"The E2 signal sequence of rubella virus remains part of the capsid protein and confers membrane association in vitro","volume":"64","author":"Suomalainen","year":"1990","journal-title":"J Virol"},{"issue":"11","key":"10.1016\/j.vaccine.2007.08.049_bib18","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1093\/nar\/17.11.4393","article-title":"Nucleotide sequence of capsid, E2 and E1 protein genes of rubella virus vaccine strain RA27\/3","volume":"17","author":"Nakhasi","year":"1989","journal-title":"Nucleic Acids Res"},{"issue":"7","key":"10.1016\/j.vaccine.2007.08.049_bib19","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.4049\/jimmunol.150.7.3080","article-title":"Monoclonal antibody to rubella virus capsid protein recognizes a beta-cell antigen","volume":"150","author":"Karounos","year":"1993","journal-title":"J Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2007.08.049_bib20","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1128\/JVI.73.2.1092-1098.1999","article-title":"Two-helper RNA system for production of recombinant Semliki Forest virus particles","volume":"73","author":"Smerdou","year":"1999","journal-title":"J Virol"},{"issue":"16","key":"10.1016\/j.vaccine.2007.08.049_bib21","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1038\/sj.gt.3302561","article-title":"Regression of mouse tumours and inhibition of metastases following administration of a Semliki Forest virus vector with enhanced expression of IL-12","volume":"12","author":"Chikkanna-Gowda","year":"2005","journal-title":"Gene Ther"},{"issue":"7","key":"10.1016\/j.vaccine.2007.08.049_bib22","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.it.2004.04.011","article-title":"The immunobiology of the TLR9 subfamily","volume":"25","author":"Wagner","year":"2004","journal-title":"Trends Immunol"},{"issue":"10","key":"10.1016\/j.vaccine.2007.08.049_bib23","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/ni1112","article-title":"Toll-like receptor control of the adaptove immune responses","volume":"5","author":"Iwasaki","year":"2004","journal-title":"Nat Immunol"},{"issue":"9","key":"10.1016\/j.vaccine.2007.08.049_bib24","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1086\/319857","article-title":"Self-replicative RNA vaccines elicit protection against influenza a virus, respiratory syncytial virus, and a tickborne encephalitis virus","volume":"183","author":"Fleeton","year":"2001","journal-title":"J Infect Dis"},{"issue":"15\u201316","key":"10.1016\/j.vaccine.2007.08.049_bib25","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1016\/S0264-410X(00)00428-X","article-title":"Semliki Forest virus-based vaccines: persistence, distribution and pathological analysis in two animal systems","volume":"19","author":"Morris-Downes","year":"2001","journal-title":"Vaccine"},{"issue":"25\u201326","key":"10.1016\/j.vaccine.2007.08.049_bib26","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.1016\/S0264-410X(01)00034-2","article-title":"Enhanced simian immunodeficiency virus-specific immune responses in macaques induced by priming with recombinant Semliki Forest virus and boosting with modified vaccinia virus Ankara","volume":"19","author":"Nilsson","year":"2001","journal-title":"Vaccine"},{"issue":"15","key":"10.1016\/j.vaccine.2007.08.049_bib27","doi-asserted-by":"crossref","first-page":"9854","DOI":"10.1128\/JVI.79.15.9854-9861.2005","article-title":"Characterization of immune responses induced by intramuscular vaccination with DNA vaccines encoding measles virus hemagglutinin and\/or fusion proteins","volume":"79","author":"Song","year":"2005","journal-title":"J Virol"},{"issue":"7","key":"10.1016\/j.vaccine.2007.08.049_bib28","doi-asserted-by":"crossref","first-page":"3579","DOI":"10.1128\/JVI.76.7.3579-3584.2002","article-title":"Inhibition of in vitro leukocyte proliferation by morbilliviruses","volume":"76","author":"Heaney","year":"2002","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2007.08.049_bib29","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S0952-7915(02)00009-2","article-title":"Epitope dominance, competition and T cell affinity maturation","volume":"15","author":"Kedl","year":"2003","journal-title":"Curr Opin Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07009966?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X07009966?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,14]],"date-time":"2023-05-14T04:44:38Z","timestamp":1684039478000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X07009966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":30,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["S0264410X07009966"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2007.08.049","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}